Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Genovis AB
Janssen Biotech adds to its bispecific antibody pipeline for cancer via pair of collaborations. Ipsen and Accent pair up to investigate new target for acute myeloid leukemia.
Start-up Insitro will attempt to optimize up to five NASH targets for Gilead under three-year alliance. Catalent buys gene therapy CDMO Paragon for $1.2bn, Boehringer partners with PureTech in GI cancer, while Fibrocell inks gene therapy pact with Castle Creek.
The Swedish group has sold its stake in Genovis, raising about $9.6m that will help advance lead candidate imlifidase.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
- Contract Research Organization-CRO
- Medical Devices
- Research, Analytical Equipment & Supplies
- Drug Discovery Tools
- Other Names / Subsidiaries
- Eijdo research AB, Genovis Inc USA, GeccoDots AB
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.